Consensus Encompass Health Corporation

Equities

EHC

US29261A1007

Market Closed - Nyse Other stock markets 04:00:02 2024-04-18 pm EDT			5-day change	1st Jan Change
78.62 ^USD	-1.34%		-3.72%	+17.84%

Apr. 11	As You Sow Files an Exempt Solicitation Statement and Request Vote for the Proposal	CI
Apr. 03	Encompass Health Plans to Build 50-Bed Rehabilitation Hospital in San Antonio	MT

Evolution of the average Target Price on Encompass Health Corporation

Price target over the last 5 years

History of analyst recommendation changes

d6edad0dac6d4.DC_gsTY-xsk3x5OHk7vk1LZTQQ5DrUfkOkrK7aj-iY0.SGCF21xNtLN4gP-y5NyijcAGAjghxhG3VXituvKz6LVDRprWflyJpgL3wg~39cc4b00f9bf56e683f5ec52a8d74444

Analyst Recommendations on Encompass Health Corporation

Barclays Raises Price Target on Encompass Health to $101 From $95, Maintains Overweight Rating	Mar. 28	MT
UBS Adjusts Encompass Health Price Target to $88 From $84, Maintains Buy Rating	Feb. 09	MT
Mizuho Raises Price Target on Encompass Health to $82 From $77, Keeps Buy Rating	Feb. 09	MT
Deutsche Bank Adjusts Encompass Health Price Target to $83 From $77, Maintains Buy Rating	Feb. 09	MT
RBC Raises Price Target on Encompass Health to $83 From $70, Cites 'Impressive Beat,' Guidance Boost; Outperform Kept	23-08-08	MT
Credit Suisse Adjusts Encompass Health's Price Target to $80 From $76, Keeps Outperform Rating	23-08-04	MT
Deutsche Bank Adjusts Encompass Health Price Target to $77 From $73, Maintains Buy Rating	23-08-03	MT
Truist Securities Adjusts Price Target on Encompass Health to $82 From $75, Maintains Buy Rating	23-08-03	MT
Mizuho Adjusts Price Target on Encompass Health to $77 From $74, Maintains Buy Rating	23-08-03	MT
Barclays Adjusts Price Target on Encompass Health to $71 From $61, Maintains Equal-Weight Rating	23-08-03	MT
UBS Adjusts Encompass Health Price Target to $84 From $77, Maintains Buy Rating	23-08-02	MT
Stephens Adjusts Price Target on Encompass Health to $78 From $74, Maintains Overweight Rating	23-06-29	MT
Raymond James Raises Price Target on Encompass Health to $80 From $72, Maintains Strong Buy Rating	23-05-02	MT
RBC Boosts Price Target on Encompass Health to $70 From $66, Maintains Outperform Rating	23-05-02	MT
Deutsche Bank Adjusts Encompass Health Price Target to $73 From $70, Maintains Buy Rating	23-05-01	MT
Stephens Adjusts Price Target on Encompass Health to $74 From $70, Maintains Overweight Rating	23-05-01	MT
Mizuho Adjusts Price Target on Encompass Health to $74 From $69, Maintains Buy Rating	23-05-01	MT
Credit Suisse Raises Encompass Health's Price Target to $76 From $73, Notes Stronger-Than-Expected Volume Trends; Keeps Outperform Rating	23-05-01	MT
UBS Adjusts Encompass Health Price Target to $77 From $73, Maintains Buy Rating	23-04-28	MT
BofA Securities Adjusts Encompass Health's Price Target to $74 From $69, Keeps Buy Rating	23-04-28	MT
Barclays Raises Encompass Health Price Target to $61 From $57, Maintains Equal Weight Rating	23-04-04	MT
Barclays Initiates Coverage on Encompass Health With Equal Weight Rating	23-03-14	MT
Truist Securities Adjusts Encompass Health's Price Target to $75 From $70, Keeps Buy Rating	23-02-09	MT
Credit Suisse Adjusts Encompass Health's Price Target to $73 From $62, Keeps Outperform Rating	23-02-09	MT
Mizuho Securities Adjusts Price Target on Encompass Health to $69 From $65, Maintains Buy Rating	23-02-09	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

78.62 USD

Average target price

89.36 USD

Spread / Average Target

+13.67%

High Price Target

101 USD

Spread / Highest target

+28.47%

Low Price Target

83 USD

Spread / Lowest Target

+5.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Encompass Health Corporation

Barclays
Deutsche Bank Securities
Mizuho Securities
UBS
RBC Capital Markets
Credit Suisse
Truist Securities
Stephens Inc.
Raymond James
BofA Securities
BMO Capital
Jefferies & Co.

Ratings for Encompass Health Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar